Program Agenda


 

 

Latin America Healthcare Compliance Certificate Program

[email protected] | 973-642-8871

PROGRAM SCHEDULED for April 25-29, 2022 | Virtual

 

All times are listed in Eastern Time.

 

DAY 1 April 19, 2021

10:00 - 10:05

Welcome & Overview
Amy Matey, Seton Hall Law School (New Jersey)

10:10 – 11:05

Aligning the “Why” and “How” of Compliance
Dean Timothy Glynn, Seton Hall Law School (New Jersey)

11:05 – 11:20

Break

11:20 – 12:45

Advertising & Promotion of Drugs & Medical Devices
Ignacio Gillmore, Carey Law Firm (Santiago)
Angela Kung, Pinheiro Neto Advogados (São Paulo)
Adrián del Paso, Ibarra, del Paso, y Gallego, S.C. (Mexico City)

12:45 – 1:30

Lunch Break

1:30 – 2:30

Drug & Device Development & Approval Process
Patricia Fukuma, Fukuma Advogados & Consultores (São Paulo)
Martiza Moncayo, IRIS GLOBAL (Chicago)

2:30 – 2:45

Break

2:45 – 3:30

Transparency in Latin America
David Quiroz, Johnson & Johnson (Bogotá)

3:35– 4:15

Optional Networking

DAY 2 April 21, 2021

10:00 – 11:30

Global Anti-Corruption Enforcement
Jonathan Stevens, Paul Hastings LLP (California)

11:30 – 11:50

Break

11:50 – 1:05

Anti-Corruption Risks & Enforcement in LATAM Markets
Vanina Caniza, Baker McKenzie (Buenos Aires)
Henrique Frizzo, Trench Rossi Watanabe (São Paulo)

1:05 – 1:50

Lunch Break

1:50 – 2:30

Antitrust Issues for Pharmaceutical and Medical Device Companies—Panel Discussion
Santiago Del Río, Marval O’Farrell Mairal (Argentina)
Matias Giaccardi, Takeda (Argentina)

2:30 – 2:40

Break

2:40 – 3:40

Compliance Officers’ Panel Discussion
Lina María Cortés, Johnson & Johnson (Bogotá)
Caterina Fazenda, BioMarin (Brazil)
Claudia Hernández Loustalot Laclette, Abbvie
Felipe Kietzmann, Grünenthal (Panama)
Moderator: Timothy Glynn, Seton Hall Law School (New Jersey)

DAY 3 April 26, 2021

10:00 – 11:05

Strengthening Compliance Programs Through Data Analytics 
Henry Matta, EY (Perú)
Cecilia Melzi, EY (Perú)

11:05 - 11:25

Break

11:25 – 12:40

Data Protection Risks in the Health Care Industry—An Accountability Approach
Ariadna Quesada, Hillrom (Amsterdam)
Benny Spiewak, SPLAW Advogados (São Paulo)

12:40 – 1:25

Lunch Break

1:25 – 2:35

Conducting an Internal Investigation
Gildas Durand, E&Y (Miami)

2:40 – 3:30

Optional Networking

DAY 4 April 28, 2021

10:00 – 11:20

Assessing Third Party Risk
Ariadna Quesada, Hillrom (Amsterdam)

11:20 – 11:40

Break

11:40 – 12:35

Monitoring Programs
Lina María Cortés, Johnson & Johnson (Bogotá)
Rafael Peña, Johnson & Johnson (Colombia)

12:35 – 1:20

Lunch Break

1:20 – 2:20

Talking To Your Government: Dealing with Enforcers & Prosecutors
Daniel Alonso, Buckley LLP (New York)
Gustavo Luis Morales Oliver, Marval, O’Farrell y Mairal (Buenos Aires)
Michel Sancovski, Mayer Brown (São Paulo)

2:20 – 2:35

Break

2:35 – 3:20

Culture, Ethics and Compliance
Imelda Alvarez, Comply Latam (Mexico)

3:25 – 4:55

Group Exercise

DAY 5 April 30, 2021

10:00 – 11:00

Industry Interactions with Patient Organizations
Marcos Lobo de Freitas Levy, A. Lopes Muniz (São Paulo)

11:00 – 11:15

Break

11:15 – 12:45

Building a Compliance Team & Creating a Culture of Compliance
Claudia Hernández Loustalot Laclette, Abbvie
Angela Neira, Abbott

12:45 – 1:30

Lunch Break

1:30 – 3:30

Interactive Team Case Study
Lina María Cortés, Johnson & Johnson (Bogotá
Claudia Hernández Loustalot Laclette, Abbvie

3:30 – 3:45

Closing remarks

 

 

 


Celebrating 15 years in Compliance


Learn more about our programs.